Literature DB >> 15311026

Transurethral holmium laser enucleation of the prostate versus transurethral electrocautery resection of the prostate: a randomized prospective trial in 200 patients.

Rainer M Kuntz1, Sascha Ahyai, Karin Lehrich, Amr Fayad.   

Abstract

PURPOSE: Transurethral electrocautery resection (TURP) is generally regarded as the gold standard surgical treatment for bladder outflow obstruction due to benign prostatic hyperplasia despite its rather high morbidity. The high powered holmium:YAG laser can be used endoscopically to enucleate obstructing prostatic tissue in a relatively bloodless manner. The technique of transurethral holmium laser enucleation of the prostate (HoLEP) was compared to standard TURP for the surgical management of prostate adenomas in a randomized, prospective clinical trial.
MATERIALS AND METHODS: A total of 200 urodynamically obstructed patients with a prostate of less than 100 gm on transrectal ultrasound were randomized to HoLEP or TURP. All patients were assessed preoperatively, and 1, 6 and 12 months postoperatively. Patient baseline characteristics, perioperative data and postoperative outcome were compared. All complications were noted.
RESULTS: HoLEP was significantly superior to TURP in terms of catheter time, hospital stay and hemoglobin loss but operative time was longer. HoLEP and TURP resulted in a significant improvement in American Urological Association symptom scores, peak urinary flow rates and post-void residual urine volumes with symptoms scores and residual volume significantly better in the holmium group. Effects on continence and potency were similar in the 2 groups but adverse events were less frequent in the holmium group.
CONCLUSIONS: HoLEP and TURP are highly effective procedures for removing obstructing prostatic adenomas. HoLEP resulted in significantly better micturition parameters and less perioperative morbidity.

Entities:  

Mesh:

Year:  2004        PMID: 15311026     DOI: 10.1097/01.ju.0000136218.11998.9e

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  86 in total

1.  2010 Update: Guidelines for the management of benign prostatic hyperplasia.

Authors:  J Curtis Nickel; Carlos E Méndez-Probst; Thomas F Whelan; Ryan F Paterson; Hassan Razvi
Journal:  Can Urol Assoc J       Date:  2010-10       Impact factor: 1.862

2.  TURP in the new century: an analytical reappraisal in light of lasers.

Authors:  Assaad El-Hakim
Journal:  Can Urol Assoc J       Date:  2010-10       Impact factor: 1.862

3.  Towards optimizing prostate tissue retrieval following holmium laser enucleation of the prostate (HoLEP): Assessment of two morcellators and review of literature.

Authors:  Ahmed M Elshal; Ramy Mekkawy; Mahmoud Laymon; Ahmed El-Assmy; Ahmed R El-Nahas
Journal:  Can Urol Assoc J       Date:  2015-09-09       Impact factor: 1.862

4.  [S2e guideline of the German urologists: Instrumental treatment of benign prostatic hyperplasia].

Authors:  T Bschleipfer; T Bach; R Berges; K Dreikorn; C Gratzke; S Madersbacher; M-S Michel; R Muschter; M Oelke; O Reich; C Tschuschke; K Höfner
Journal:  Urologe A       Date:  2016-02       Impact factor: 0.639

Review 5.  New laser treatment approaches for benign prostatic hyperplasia.

Authors:  Nathaniel M Fried
Journal:  Curr Urol Rep       Date:  2007-01       Impact factor: 3.092

6.  [Transurethral enucleation of the prostate with the holmium: YAG laser system: how much power is necessary?].

Authors:  J Rassweiler; M Roder; M Schulze; R Muschter
Journal:  Urologe A       Date:  2008-04       Impact factor: 0.639

Review 7.  [Laser-based resecting techniques in the treatment of benign prostatic obstruction].

Authors:  A J Gross; T Bach
Journal:  Urologe A       Date:  2008-04       Impact factor: 0.639

8.  Holmium laser enucleation of the prostate: a paradigm shift in benign prostatic hyperplasia surgery.

Authors:  Tevita F Aho
Journal:  Ther Adv Urol       Date:  2013-10

9.  Overview of interventional treatment options for benign prostatic hyperplasia.

Authors:  Mostafa M Elhilali
Journal:  Can Urol Assoc J       Date:  2012-10       Impact factor: 1.862

10.  [Operative therapy of benign prostatic hyperplasia: enucleation procedures (HoLEP and ThuVEP)].

Authors:  T Bach; T Bschleipfer; R Muschter
Journal:  Urologe A       Date:  2013-03       Impact factor: 0.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.